Symbiotec Pharmalab IPO
The Symbiotec Pharmalab IPO was a ₹1,757 crore mainboard issue (fresh issue and offer for sale), open for bidding from 24 Aug to 27 August 2026 at a price band of ₹938 to ₹988. The final issue price was ₹988. It was subscribed 71.26 times overall, and 12.96 times in the retail category. Shares listed on NSE and BSE on 1 September 2026 at ₹988.00, 0.0% above the issue price, and closed the first day at ₹1,097.70.
- Listing gain at open
- 0.0%₹988.00 vs ₹988
- Issue price
- ₹988Band ₹938 to ₹988
- Lot size
- 15 sharesMinimum ₹14,820
- Issue size
- ₹1,757 crore
- Subscribed
- 71.26xOverall
- Listed
- 1 Sep 2026NSE, BSE
Price and lots
Symbiotec Pharmalab IPO details
NSE issue details| Bidding dates | 24 Aug 2026 to 27 Aug 2026 |
| Listing date | 1 September 2026 |
| Price band | ₹938 to ₹988 |
| Final issue price | ₹988 |
| Face value | ₹2 per share |
| Lot size | 15 shares |
| Minimum investment | ₹14,820 (15 shares, our calculation) |
| Retail maximum | 13 lots (₹1,92,660), under ₹2 lakh (our calculation) |
| Issue size | ₹1,757 crore (our calculation from the NSE issue details) |
| Type of issue | Book Building, Fresh issue and offer for sale |
| Employee discount | ₹90 per share |
| Listed on | NSE and BSE |
| NSE symbol | SYMBIOTEC |
| BSE code | 544889 |
| ISIN | INE899I01028 |
| Lead managers | JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited, Nomura Financial Advisory, Securities (India) Private Limited |
| Registrar | MUFG Intime India Private Limited |
Subscription and listing
Symbiotec Pharmalab IPO subscription and listing
NSE and BSEFinal subscription
NSE issue details- QIBs172.03x
- Non-institutional (NII)73.63x
- NII above ₹10 lakh82.92x
- NII ₹2 lakh to ₹10 lakh55.07x
- Retail12.96x
- Employees15.41x
- Total71.26x
Times subscribed at the close of bidding, as published by NSE. It is a fact about demand, not a sign of quality.
Listing day
Our calculation: gains vs issue price| NSE | BSE | |
|---|---|---|
| Open | ₹988.00 | ₹978.20 |
| High | ₹1,180.00 | - |
| Low | ₹934.20 | - |
| Close | ₹1,097.70 | ₹1,095.95 |
| Gain at open | 0.0% | −1.0% |
| Gain at close | +11.1% | +10.9% |
| Shares traded | 3,01,02,923 | - |
Latest: closed at ₹1,513.60 on NSE on 6 November 2026, +53.2% vs the issue price (our calculation). Past returns say nothing about future returns.
How it compares
How the Symbiotec Pharmalab IPO compares
Our calculation: 2026 mainboard IPOs on IPO24by7Among 109 mainboard IPOs of 2026 on our tracker, the Symbiotec Pharmalab IPO's subscription of 71.26 times ranks 34th of 109, and its listing gain of 0.0% at open ranks 75th of 107. By issue size it ranks 18th. The median listing-day gain at open for mainboard IPOs this year is +7.6%. See all 2026 IPOs with listing gains or the IPO calendar for September 2026.
Other mainboard IPOs listed in September 2026
| IPO | Listed | Issue price | Subscribed | Gain at open |
|---|---|---|---|---|
| Adroit Industries (India) | 30 Sep 2026 | ₹134 | 176.85x | +75.4% |
| ArMee Infotech | 30 Sep 2026 | ₹375 | 2.44x | 0.0% |
| Elevate Campuses | 30 Sep 2026 | ₹362 | 1.79x | −1.9% |
| Swastika Infra | 30 Sep 2026 | ₹185 | 7.60x | +8.1% |
| Varmora Granito | 29 Sep 2026 | ₹148 | 1.58x | +4.7% |
| National Stock Exchange of India | 24 Sep 2026 | ₹1,785 | 5.71x | +0.8% |
Allotment
Symbiotec Pharmalab IPO allotment status
- Open the registrar's pageMUFG Intime India Private Limited is the registrar. Open its allotment page.
- Select Symbiotec Pharmalab LimitedOlder issues may move to an archive list on the registrar's site.
- Enter your PAN, application number or DP IDUse the details you applied with.
- Or check your demat accountAllotted shares were credited before the listing day.
Documents
Questions
Symbiotec Pharmalab IPO FAQs
What was the Symbiotec Pharmalab IPO price band?
The price band was ₹938 to ₹988 per share and the final issue price was ₹988. The face value is ₹2 per share.
What was the Symbiotec Pharmalab IPO lot size?
One lot was 15 shares. The minimum investment at the issue price was ₹14,820. Retail investors could apply for up to 13 lots.
How many times was the Symbiotec Pharmalab IPO subscribed?
It was subscribed 71.26 times overall, as published by NSE. QIBs bid 172.03 times their quota, NIIs 73.63 times and retail investors 12.96 times.
What was the Symbiotec Pharmalab IPO listing price?
It opened at ₹988.00 on NSE and BSE on 1 September 2026, a gain of 0.0% over the issue price of ₹988 (our calculation). It closed the day at ₹1,097.70.
How do I check Symbiotec Pharmalab IPO allotment status?
MUFG Intime India Private Limited is the registrar. Select Symbiotec Pharmalab Limited on its allotment page and enter your PAN, application number or DP ID. You can also check on the NSE or BSE application status page.
Was the Symbiotec Pharmalab IPO a fresh issue or an offer for sale?
Fresh issue and offer for sale, as stated in the NSE issue details.
Who were the lead managers of the Symbiotec Pharmalab IPO?
JM Financial Limited, Avendus Capital Private Limited, Motilal Oswal Investment Advisors Limited, Nomura Financial Advisory, Securities (India) Private Limited.
Sources: NSE public issue information and IPO detail pages; NSE and BSE end-of-day bhavcopy files. Gains, issue size and minimum investment are our calculations. This page is information only, not a recommendation.